1 Min Read
June 14 (Reuters) - Eiger Biopharmaceuticals Inc
* Eiger announces appointment of biopharmaceutical industry veteran David Apelian, MD, PHD, MBA to its board of directors Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.